Survival analysis in breast cancer using proteomic data from four independent datasets

Abstract Breast cancer clinical treatment selection is based on the immunohistochemical determination of four protein biomarkers: ESR1, PGR, HER2, and MKI67. Our aim was to correlate immunohistochemical results to proteome-level technologies in measuring the expression of these markers. We also aime...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ágnes Ősz, András Lánczky, Balázs Győrffy
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/98b06f65bfd74ceea979747b3df6d25b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!